Jacob S. Choi

Jacob S. Choi

Hematology | Oncology

675 N St Clair St Ste 21-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 15, 2026

An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor Therapy.

An Indolent Enteropathy Accelerated by Combination Immune Checkpoint Inhibitor Therapy.

Journal: ACG case reports journal

Published: February 12, 2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Journal: Cancers

Published: November 27, 2025

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management.

Journal: Journal of the American Academy of Dermatology

Published: June 30, 2025

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.

Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.

Journal: EClinicalMedicine

Published: May 14, 2025

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.

Journal: The British journal of dermatology

Published: July 30, 2024

Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.

Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 25, 2024

New Approaches to Targeted Therapy in Melanoma.

New Approaches to Targeted Therapy in Melanoma.

Journal: Cancers

Published: May 29, 2023

Reply to O. Devlin et al.

Reply to O. Devlin et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 15, 2023

Melanoma: Does Sequencing Really Matter?

Melanoma: Does Sequencing Really Matter?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 20, 2022

Targeted Therapy for Melanomas Without BRAF V600 Mutation.

Targeted Therapy for Melanomas Without BRAF V600 Mutation.

Journal: Current oncology reports

Published: June 10, 2022

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: April 14, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026